Clorox's Q2 2025 net sales decreased by 15% to $1.69 billion, while diluted EPS increased by 105% to $1.54 and adjusted EPS decreased by 28% to $1.55. The company has updated its fiscal year 2025 outlook, expecting net sales to be down 1% to up 2% and adjusted EPS to be between $6.95 and $7.35.
Net sales decreased 15% to $1.69 billion, primarily due to lapping the impact of retail inventory restoration following the August 2023 cyberattack and divestitures.
Diluted EPS increased 105% to $1.54, including lapping the pension settlement charge and cyberattack expenses.
Adjusted EPS decreased 28% to $1.55, primarily due to lower net sales, partially offset by cost savings.
Gross margin increased 30 basis points to 43.8%, driven by cost savings and divestiture benefits.
Clorox updated its fiscal year 2025 outlook, expecting net sales to be down 1% to up 2% and adjusted EPS to be between $6.95 and $7.35.
Visualization of income flow from segment revenue to net income